Bonnefont-Rousselot D - Search Results

1

Low lipolytic enzyme activity in patients with severe hypertriglyceridemia on highly active antiretroviral therapy.

Baril L, Beucler I, Valantin MA, Bruckert E, Bonnefont-Rousselot D, Coutellier A, Caumes E, Katlama C, Bricaire F. Baril L, et al. AIDS. 2001 Feb 16;15(3):415-7. doi: 10.1097/00002030-200102160-00016. AIDS. 2001. PMID: 11273223 No abstract available.

2

[Oxidative stress in 29 HIV seropositive patients. Two-year results of a double-blind trial of diethyldithiocarbamate versus placebo].

Coutellier A, Bonnefont-Rousselot D, Delattre J, Lopez O, Jaudon MC, Herson S, Emerit J. Coutellier A, et al. Presse Med. 1992 Nov 14;21(38):1809-12. Presse Med. 1992. PMID: 1337206 Clinical Trial. French.

3

Blood antioxidants (vitamin E and beta-carotene) in long-term low density lipoprotein apheresis.

Assogba U, Lepage S, Bruckert E, Bonnefont-Rousselot D, Dairou F, de Gennes JL, Delattre J. Assogba U, et al. Clin Chim Acta. 1995 Mar 31;235(2):147-57. doi: 10.1016/0009-8981(95)06021-9. Clin Chim Acta. 1995. PMID: 7554269

4

Antioxidant status of hypercholesterolemic patients treated with LDL apheresis.

Lepage S, Bonnefont-Rousselot D, Bruckert E, Bourely B, Jaudon MC, Delattre J, Assogba U. Lepage S, et al. Cardiovasc Drugs Ther. 1996 Nov;10(5):567-71. doi: 10.1007/BF00050998. Cardiovasc Drugs Ther. 1996. PMID: 8950072 Clinical Trial.

5

[The plasma antioxidant status and trace elements in patients with familial hypercholesterolemia treated with LDL-apheresis].

Delattre J, Lepage S, Jaudon MC, Bruckert E, Assogba U, Bonnefont-Rousselot D. Delattre J, et al. Ann Pharm Fr. 1998;56(1):18-25. Ann Pharm Fr. 1998. PMID: 9770031 Clinical Trial. French.

6

Modifications of alpha-tocopherol and fatty acid concentrations in blood and adipose tissue of obese patients during a weight loss programme.

Bonnefont-Rousselot D, Lepage S, Thérond P, Bastard JP, Hainque B, Turpin G, Legrand A, Delattre J, Bruckert E. Bonnefont-Rousselot D, et al. Nutr Metab Cardiovasc Dis. 1999 Feb;9(1):25-32. Nutr Metab Cardiovasc Dis. 1999. PMID: 10726106 Clinical Trial.

7

Oxidizability of atherogenic low-density lipoprotein subspecies in severe familial hypercholesterolemia: impact of long-term low-density lipoprotein apheresis.

Lepage S, Nigon F, Bonnefont-Rousselot D, Assogba U, Goulinet S, Chancharme L, Delattre J, Bruckert E, Chapman MJ. Lepage S, et al. J Cardiovasc Pharmacol Ther. 2000 Apr;5(2):87-103. doi: 10.1053/XV.2000.5588. J Cardiovasc Pharmacol Ther. 2000. PMID: 11150388 Clinical Trial.

8

Could antioxidant supplementation reduce antiretroviral therapy-induced chronic stable hyperlactatemia?

Lopez O, Bonnefont-Rousselot D, Edeas M, Emerit J, Bricaire F. Lopez O, et al. Biomed Pharmacother. 2003 May-Jun;57(3-4):113-6. doi: 10.1016/s0753-3322(03)00017-9. Biomed Pharmacother. 2003. PMID: 12818471

9

Blood oxidative stress markers are unreliable markers of hepatic steatosis.

Bonnefont-Rousselot D, Ratziu V, Giral P, Charlotte F, Beucler I, Poynard T; Lido Study Group. Bonnefont-Rousselot D, et al. Aliment Pharmacol Ther. 2006 Jan 1;23(1):91-8. doi: 10.1111/j.1365-2036.2006.02719.x. Aliment Pharmacol Ther. 2006. PMID: 16393285

10

One third of the variability in HDL-cholesterol level in a large dyslipidaemic population is predicted by age, sex and triglyceridaemia: The Paris La Pitié Study.

Hansel B, Kontush A, Giral P, Bonnefont-Rousselot D, Chapman MJ, Bruckert E. Hansel B, et al. Curr Med Res Opin. 2006 Jun;22(6):1149-60. doi: 10.1185/030079906X104821. Curr Med Res Opin. 2006. PMID: 16846548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters